ClinicalTrials.Veeva

Menu

Tempus Pro Monitor Registry

Philips logo

Philips

Status

Completed

Conditions

Emergency Care
Sudden Cardiac Arrest

Treatments

Diagnostic Test: Standard of Care

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT05587764
CCTCRDTTempusProRegi20211168

Details and patient eligibility

About

A multicenter, prospective and retrospective, observational, post market study.

Full description

This observational study is to collect real-world data on the safety and performance of the Tempus Pro device, its accessories and the IntelliSpace Corsium telemedicine software device when used according to its intended purpose and the instructions for use, when used for patient monitoring.

Enrollment

103 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients monitored by using Tempus Pro during pre-hospital care (ambulance transportation)

One or more 12-lead ECG recorded

Use of 3 or more of the following sensors to measure vital signs

  • NIBP (Non-Invasive Blood Pressure)
  • HR (Heart Rate)
  • SpO2 (Oxygen Saturation)
  • PVI (Pleth Variability Index)
  • SpCO (Carboxyhemoglobin)
  • SpOC (Oxygen Content)
  • SpHb (Total Hemoglobin)
  • SpMet (Methemoglobin Saturation)
  • EtCO2 (End-tidal Carbon Dioxide)

Exclusion criteria

  • None defined

Trial design

103 participants in 1 patient group

Standard of Care
Description:
Standard of Care for emergency care
Treatment:
Diagnostic Test: Standard of Care

Trial contacts and locations

1

Loading...

Central trial contact

Tiffani Bowers

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems